Antiplatelet agents for chronic kidney disease

被引：1
|
作者：
Webster, Angela
Palmer, Suetonia
Saglimbene, Valeria
Strippoli, Giovanni F. M.
机构：
来源：
NEPHROLOGY | 2013年 / 18卷 / 06期
关键词：
D O I：
10.1111/nep.12055
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：474 / 476
页数：3
相关论文
共 50 条
  • [31] Novel Antiplatelet Agents in Cardiovascular Disease
    Tscharre, Maximilian
    Michelson, Alan D.
    Gremmel, Thomas
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 25 (03) : 191 - 200
  • [32] New antiplatelet agents for cardiovascular disease
    Chua, Doson
    Nishi, Cesilia
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2013, 185 (16) : 1405 - 1411
  • [33] Contemporary Time Trends in Use of Antiplatelet Agents Among Patients with Acute Coronary Syndrome and Comorbid Diabetes Mellitus or Chronic Kidney Disease
    Desai, Rishi J.
    Spoendlin, Julia
    Mogun, Helen
    Gagne, Joshua J.
    PHARMACOTHERAPY, 2017, 37 (10): : 1322 - 1327
  • [34] Anemia of chronic kidney disease: Will new agents deliver on their promise?
    Souaid, Tarek
    Taliercio, Jonathan
    Simon, James F.
    Mehdi, Ali
    Nakhoul, Georges N.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2022, 89 (04) : 212 - 222
  • [35] Novel Hypoglycaemic Agents: Considerations in Patients with Chronic Kidney Disease
    Game, Fran
    NEPHRON CLINICAL PRACTICE, 2014, 126 (01): : 14 - 18
  • [36] IMPACT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH AS USING BIOLOGIC AGENTS
    Uzun, G. Sandal
    Cakir, I. Y.
    Bilgin, E.
    Farisogullari, B.
    Ayan, G.
    Ozsoy, Z.
    Ekici, M.
    Unaldi, E.
    Germe, S. A.
    Firlatan, B.
    Bayram, G. S. Kart
    Kilic, L.
    Karadag, O.
    Akdogan, A.
    Bilgen, S. A.
    Kiraz, S.
    Ertenli, A. I.
    Kalyoncu, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1695 - 1695
  • [37] ADHERENCE TO A GUIDELINE FOR ERYTHROPOIESIS STIMULATING AGENTS IN CHRONIC KIDNEY DISEASE
    Yeh, Y. C.
    Clapp, M. D.
    Churchill, W. W.
    O'Day, J.
    Reddy, P.
    VALUE IN HEALTH, 2010, 13 (03) : A80 - A80
  • [38] Biosimilar Erythropoiesis-Stimulating Agents in Chronic Kidney Disease
    Shah, Hitesh H.
    Fishbane, Steven
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (04) : 267 - 271
  • [39] Antiplatelet Treatment in Peripheral Arterial Disease: The Role of Novel Antiplatelet Agents
    Klonaris, Chris
    Patelis, Nikolaos
    Drebes, Anja
    Matheiken, Sean
    Liakakos, Theodoros
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (29) : 4610 - 4616
  • [40] Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease
    Kao, Chih-Chin
    Wu, Mai-Szu
    Chuang, Ming-Tsang
    Lin, Yi-Cheng
    Huang, Chun-Yao
    Chang, Wei-Chiao
    Chen, Chih-Wei
    Chang, Tzu-Hao
    PLOS ONE, 2021, 16 (08):
12345